• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1804300-08
Device Problems Material Rupture (1546); Improper or Incorrect Procedure or Method (2017); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/15/2023
Event Type  Injury  
Event Description
It was reported that the procedure was performed to treat a lesion in the circumflex coronary artery with no calcification and no tortuosity.The 3.0x08 xience skypoint stent delivery system (sds) was advanced to the lesion and then prepped.Inflation was attempted.The balloon was able to get to 16 atmospheres after one inflation; however, the device was not holding pressure and a rupture was noted.The stent was 90% deployed.A non-compliant (nc) balloon was used for post-dilatation to complete deployment of the stent.There were no adverse patient effects and there was no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.H6: device code 2017 clarifier: incorrect prep.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported difficulties.The reported treatment appears to be related to operational context of the procedure.It was reported xience skypoint stent delivery system (sds) was advanced to the lesion and then prepped, and then inflation was attempted.It should be noted that the xience skypoint everolimus eluting coronary stent system instruction for use states: while introducing the delivery system into the vessel, do not induce negative pressure on the delivery system.This may cause dislodgement of the stent from the balloon.In this case, it does not appear the instruction for use (ifu) deviation related to incorrect stent preparation contributed to the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event Description
It was reported that the procedure was performed to treat a lesion in the circumflex coronary artery with no calcification and no tortuosity.The 3.0x08 xience skypoint stent delivery system (sds) was advanced to the lesion and then prepped, and then inflation was attempted.The balloon was able to get to 16 atmospheres after one inflation; however, the device was not holding pressure and a rupture was noted.The stent was 90% deployed.A non-compliant (nc) balloon was used for post-dilatation to complete deployment of the stent.There were no adverse patient effects and there was no clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17671692
MDR Text Key322523835
Report Number2024168-2023-09575
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233210
UDI-Public08717648233210
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1804300-08
Device Lot Number3041341
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NON-COMPLIANT (NC) BALLOON
Patient Outcome(s) Required Intervention;
-
-